Markus Hengstschläger Selected Research

Markus Hengstschläger Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 12/2003
18	Tuberous Sclerosis (Bourneville's Disease) 12/2021 - 01/2003
6	Melanoma (Melanoma, Malignant) 01/2022 - 11/2016
5	Inborn Genetic Diseases (Disease, Hereditary) 09/2011 - 11/2005
3	Hypoxia (Hypoxemia) 01/2017 - 12/2012
3	Carcinoma (Carcinomatosis) 12/2014 - 09/2006
3	Breast Neoplasms (Breast Cancer) 08/2013 - 03/2004
3	Autoimmune Diseases (Autoimmune Disease) 08/2013 - 10/2008
3	Neuroblastoma 08/2008 - 05/2006
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2019
2	Birth Weight (Birth Weights) 01/2021 - 05/2012
2	Carcinogenesis 10/2019 - 09/2011
2	Leukemia 01/2018 - 07/2009
2	Inflammation (Inflammations) 11/2017 - 10/2008
2	Choriocarcinoma 08/2017 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 02/2015 - 07/2012
2	Hamartoma 07/2009 - 09/2005
2	Alzheimer Disease (Alzheimer's Disease) 09/2006 - 11/2005
2	Down Syndrome (Down's Syndrome) 11/2005 - 04/2004
1	Aneuploidy (Aneuploid) 01/2022
1	Adenocarcinoma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Colitis 10/2019
1	Lymphoma (Lymphomas) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Disease Progression 01/2017
1	Tuberous Sclerosis 2 01/2017
1	Sarcoidosis (Schaumann Disease) 01/2017
1	Granuloma 01/2017
1	Hypertrophy 01/2017
1	Lung Injury 09/2015
1	Acute Lung Injury 09/2015
1	Pneumonia (Pneumonitis) 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 08/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2015

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2016 - 04/2004
10	trans-sodium crocetinate (crocetin)IBA 12/2021 - 01/2003
9	Tuberous Sclerosis Complex 2 ProteinIBA 08/2013 - 12/2003
6	Pharmaceutical PreparationsIBA 01/2017 - 11/2012
6	TOR Serine-Threonine KinasesIBA 07/2014 - 10/2008
5	Mechanistic Target of Rapamycin Complex 1IBA 10/2019 - 09/2010
5	Tuberous Sclerosis Complex 1 ProteinIBA 07/2009 - 12/2003
4	Phosphotransferases (Kinase)IBA 01/2017 - 09/2008
4	Sirolimus (Rapamycin)FDA Link 05/2016 - 07/2009
3	CholesterolIBA 01/2022 - 08/2015
3	HDL LipoproteinsIBA 01/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2003
3	CytokinesIBA 10/2019 - 09/2015
3	high density lipoprotein receptorsIBA 03/2019 - 08/2015
3	EnzymesIBA 11/2017 - 04/2004
3	Small Interfering RNA (siRNA)IBA 05/2016 - 03/2012
3	Cyclin-Dependent Kinase Inhibitor p27IBA 08/2013 - 09/2006
2	ProteomeIBA 01/2022 - 02/2015
2	LipidsIBA 01/2022 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2014
2	Mechanistic Target of Rapamycin Complex 2IBA 10/2019 - 09/2010
2	Scavenger Receptors (Scavenger Receptor)IBA 03/2019 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 09/2008
2	MercuryIBA 01/2016 - 10/2010
2	LipopolysaccharidesIBA 09/2015 - 04/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 12/2012
2	Protein Kinases (Protein Kinase)IBA 02/2013 - 06/2009
2	Biological ProductsIBA 09/2011 - 06/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	dichlorobis(azomycin)platinum IIIBA 01/2022
1	VemurafenibIBA 01/2022
1	MAP-kinase-activated kinase 2IBA 12/2021
1	Apoptosis Regulatory ProteinsIBA 12/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	OsteopontinIBA 10/2019
1	Aurora KinasesIBA 01/2018
1	STAT5 Transcription FactorIBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2017
1	InterleukinsIBA 11/2017
1	Methionine (L-Methionine)FDA Link 08/2017
1	RNA (Ribonucleic Acid)IBA 08/2017
1	Leucine (L-Leucine)FDA Link 08/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	AntibodiesIBA 11/2016
1	ParaffinIBA 11/2016
1	Eukaryotic Initiation Factor-3IBA 09/2015
1	MTOR InhibitorsIBA 09/2015
1	Everolimus FDA Link 09/2015
1	Oleic Acid (Oleate)IBA 09/2015
1	dactolisibIBA 09/2015
1	Messenger RNA (mRNA)IBA 08/2015
1	AndrogensIBA 08/2015
1	Surface-Active Agents (Surfactants)IBA 02/2015
1	IgA receptor (protein B)IBA 02/2015
1	Atorvastatin (Lipitor)FDA Link 02/2015
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 02/2015

Therapy/Procedure

9	Therapeutics 01/2022 - 06/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Transplantation 12/2009 - 10/2008
1	Injections 01/2022
1	Castration 08/2015